Simple Summary This study examined whether the timing of lung cancer surgery may be associated with long-term outcomes. Among 587 patients with early-stage NSCLC, those undergoing surgery in autumn or winter showed better survival, while time of day and day of week were not associated with outcome. A simple model combi...
Giovanni Leuzzi, P. Minicozzi, P. Verderio et al.· Cancers· 0 citations
BACKGROUND
Composite scores such as Lung Immune Prognostic Index (LIPI), modified Glasgow Prognostic Score (mGPS), EPSILoN, Pan Immune-Inflammation Value (PIV) and Systemic Immune-Inflammation Index (SII) have shown prognostic value in solid tumors, but evidence in extensive-stage small-cell lung cancer (ES-SCLC) are l...
Teresa Beninato, Giulia Stasi, G. Montelatici et al.· Tumori· 0 citations
This study aimed to assess the efficacy and safety of ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated NSCLC whose disease progressed after third-generation EGFR tyrosine kinase inhibitor (TKI) therapy.
X. Le, A. Passaro, Yuan-Yuan Zhao et al.· The Lancet Oncology· 0 citations
This is the first study to benchmark SLMs on Italian EHRs and investigate the role of clinical expertise in prompt engineering, offering valuable insights for the future integration of SLMs into real-world clinical workflows.
Federica Corso, V. Peppoloni, L. Mazzeo et al.· Communications Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.